Menopause and depression: a Lancet review reported by Brigham and Women's found no evidence it universally raises the risk
Harvard Gazette, byline BWH Communications · Mar 11, 2024 (page modified Feb 4, 2025) · review of earlier studies in The Lancet, no sample reported
The review separates a stage of life from a diagnosis. According to the page, severe depression during the transition appeared only in people with an earlier diagnosis, while depressive symptoms were more common among those with prior depression, sleep broken by hot flushes at night, or a stressful event at the same time. The authors raise the concern that blaming distress on menopause could delay accurate diagnosis. The evidence comes mostly from high-income countries, and it is thinner for anxiety, bipolar disorder and psychosis.
Why it matters to this work. The review sorts out who reported depressive symptoms around menopause and what else was happening in their lives. It reads earlier studies and does not follow new participants. Invisible Contracts
When you feel off during a season of change, which explanations do you reach for first, and which do you skip?
Where Are You Standing? → Six questions, two minutes, no email.The story
IllustrationThe Harvard Gazette page, from Brigham and Women's Hospital communications, describes a review in The Lancet of earlier studies on depressive symptoms, major depression, anxiety, bipolar disorder and psychosis during menopause. It reports no evidence that menopause universally raises the risk of these conditions. Some studies linked menopause to depressive symptoms, but more severe clinical depression during the transition occurred only in people previously diagnosed with depression. The groups named as higher risk for depressive symptoms included people with a previous history of depression, people whose sleep was severely disrupted by hot flushes at night, people who had a stressful life event alongside menopause, and people with a very long transition. Evidence for anxiety, bipolar disorder and psychosis was described as weaker because the literature is scarcer.
The page gives the transition as lasting four to 10 years and beginning at about age 47 on average. The review gave greater weight to prospective studies that assessed mental health before menopause as well as during or after it. The page states that most menopause studies come from high-income countries, that little is known about menopause in transgender and gender-diverse people, and that the evidence on anxiety, bipolar disorder and psychosis is thinner than on depression. It reports no sample size, since this is a review. The authors say that misattributing distress to menopause could delay accurate diagnosis and could create negative expectations for women approaching middle age.
More from James
- The 35 Chains: For the One at War With the MirrorFrom the Commission. Thirty-five chains, and the thirty-five truths that dissolve them, written for this reader.
- The 35 Chains: For Those Who Are Needed More Than They Are SeenFrom the Commission. Thirty-five chains, and the thirty-five truths that dissolve them, written for this reader.
- The 35 Chains: For the One Without the Child They Longed ForFrom the Commission. Thirty-five chains, and the thirty-five truths that dissolve them, written for this reader.
- The 35 Chains: For Women Who Have Given Themselves to the Work of Raising ChildrenFrom the Commission. Thirty-five chains, and the thirty-five truths that dissolve them, written for this reader.
- A hypothetical woman who lost 15% of body weight with a GLP-1 drug was rated more harshly than one who used diet and exercise, a 402-woman vignette study foundThe outcome in the vignette was the same in both versions.
- Menopause cliff study: a Nature Medicine analysis of over a million women found abrupt lab changes at the final period, and outside researchers dispute the word cliffThe study counts lab values around a single event, the final menstrual period, and the reported step appears in 52 of 90 tests in the US dataset.